STAAR Surgical raises pay for interim co-CEO/CFO
STAAR Surgical Company updated the compensation of Deborah Andrews, its Interim Co-Chief Executive Officer and Chief Financial Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
STAAR Surgical Company updated the compensation of Deborah Andrews, its Interim Co-Chief Executive Officer and Chief Financial Officer. Effective June 8, 2026, her annual base salary increases from $512,000 to $575,000. Her target annual cash bonus also rises from 55% to 60% of base salary, reflecting a review of market data and her contributions to the company’s strategic and operational objectives.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Previous base salary: $512,000 per year
New base salary: $575,000 per year
Old target bonus: 55% of base salary
+3 more
6 metrics
Previous base salary
$512,000 per year
Deborah Andrews’ base salary before June 8, 2026
New base salary
$575,000 per year
Deborah Andrews’ salary effective June 8, 2026
Old target bonus
55% of base salary
Target annual cash bonus before the change
New target bonus
60% of base salary
Target annual cash bonus effective June 8, 2026
Effective date
June 8, 2026
Date compensation changes become effective
Form type
8-K Item 5.02
Disclosure of officer compensatory arrangements
Key Terms
Compensation Committee, target annual cash bonus, Interim Co-Chief Executive Officer, principal executive offices, +1 more
5 terms
Compensation Committee financial
"On June 8, 2026, the Compensation Committee (the “Committee”) of the Board of Directors..."
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
target annual cash bonus financial
"the Committee approved an increase in the target annual cash bonus for Ms. Andrews..."
Interim Co-Chief Executive Officer financial
"Deborah Andrews, the Company's Interim Co-Chief Executive Officer and Chief Financial Officer..."
principal executive offices financial
"25510 Commercentre Drive Lake Forest , California ... (Address of principal executive offices)"
Emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What executive compensation change did STAAR Surgical (STAA) disclose?
STAAR Surgical increased compensation for Deborah Andrews, Interim Co-CEO and CFO. Her base salary rises to $575,000 and her target cash bonus increases to 60% of salary, reflecting market data and recognition of her contributions to strategic and operational objectives.
What is Deborah Andrews’ new base salary at STAAR Surgical (STAA)?
Deborah Andrews’ new annual base salary is $575,000. This is an increase from $512,000, approved by the Compensation Committee, and is effective June 8, 2026, for her role as Interim Co-Chief Executive Officer and Chief Financial Officer.
How did STAAR Surgical (STAA) change Deborah Andrews’ target bonus?
Her target annual cash bonus increased from 55% to 60% of base salary. This higher bonus opportunity applies starting June 8, 2026, and was approved after the Compensation Committee reviewed competitive market compensation data for comparable executive roles.
When do the compensation changes for Deborah Andrews at STAAR Surgical (STAA) take effect?
The compensation changes take effect on June 8, 2026. From that date, Deborah Andrews’ base salary is $575,000 and her bonus target is 60% of salary, covering her responsibilities as Interim Co-Chief Executive Officer and Chief Financial Officer.
Why did STAAR Surgical (STAA) raise Deborah Andrews’ pay?
The Compensation Committee increased her pay after reviewing competitive market compensation data. The filing also states the changes recognize Deborah Andrews’ contributions to STAAR Surgical’s strategic and operational objectives in her dual role as Interim Co-CEO and CFO.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates